Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene
- PMID: 28011390
- DOI: 10.1016/j.bcmd.2016.12.005
Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene
Abstract
Acute intermittent porphyria (AIP) is an autosomal dominant disorder caused by a partial deficiency of porphobilinogen deaminase (PBGD), the third enzyme in the of heme biosynthetic pathway. It can affect the autonomic, peripheral, and central nervous system. Posterior reversible encephalopathy syndrome is a clinicoradiological entity characterized by headache, seizures, altered consciousness, and visual disorder associated with potentially reversible neuroradiological abnormalities predominantly in the parieto-occipital lobes. Establishing accurate diagnoses of the patient and asymptomatic family members with AIP involves identifying the PBGD enzyme mutations directly. In this study, we report a 28-year-old woman with acute intermittent porphyria who presented with radiological manifestations suggestive of posterior reversible encephalopathy syndrome, she had a novel PBGD frame shift mutation, base 875 and 876 have been deleted resulting in glutamine to a stop codon (Gln292fs), in a Chinese family.
Keywords: Acute porphyria; Gene mutation; Posterior reversible encephalopathy syndrome.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.Orphanet J Rare Dis. 2020 Apr 19;15(1):98. doi: 10.1186/s13023-020-01375-y. Orphanet J Rare Dis. 2020. PMID: 32306994 Free PMC article.
-
A novel mutation in the porphobilinogen deaminase gene in an extended Chinese family with acute intermittent porphyria.Gene. 2015 Jul 10;565(2):288-90. doi: 10.1016/j.gene.2015.04.027. Epub 2015 Apr 11. Gene. 2015. PMID: 25870942
-
Posterior reversible encephalopathy syndrome in acute intermittent porphyria.Pediatr Neurol. 2014 Sep;51(3):457-60. doi: 10.1016/j.pediatrneurol.2014.05.016. Epub 2014 May 21. Pediatr Neurol. 2014. PMID: 25035140
-
May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population.Physiol Res. 2006;55 Suppl 2:S119-136. doi: 10.33549/physiolres.930000.55.S2.119. Physiol Res. 2006. PMID: 17298216 Review.
-
Porphobilinogen deaminase gene structure and molecular defects.J Bioenerg Biomembr. 1995 Apr;27(2):197-205. doi: 10.1007/BF02110034. J Bioenerg Biomembr. 1995. PMID: 7592566 Review.
Cited by
-
Acute porphyrias - A neurological perspective.Brain Behav. 2021 Nov;11(11):e2389. doi: 10.1002/brb3.2389. Epub 2021 Oct 17. Brain Behav. 2021. PMID: 34661997 Free PMC article. Review.
-
Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: Two case reports and a literature review.Medicine (Baltimore). 2018 Sep;97(36):e11665. doi: 10.1097/MD.0000000000011665. Medicine (Baltimore). 2018. PMID: 30200061 Free PMC article. Review.
-
Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.Orphanet J Rare Dis. 2020 Apr 19;15(1):98. doi: 10.1186/s13023-020-01375-y. Orphanet J Rare Dis. 2020. PMID: 32306994 Free PMC article.
-
Clinical feature and genetic analysis of HMBS gene in Chinese patients with acute intermittent porphyria: a systematic review.Front Genet. 2023 Dec 11;14:1291719. doi: 10.3389/fgene.2023.1291719. eCollection 2023. Front Genet. 2023. PMID: 38148975 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous